Representantes de Ventas (Alto Costo) Ejecutivo Oncología - Medellín

Colombia

Apply with AI Apply

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Candidates should be healthcare professionals such as physicians, nurses, or pharmaceutical chemists, or administrative professionals with experience in high-cost medical sales. A strong interest in commercial and business areas, passion for patients, and a desire to develop a career in the pharmaceutical industry are essential. Skills in data analysis and interpretation, flexibility, adaptability to change, and a winning attitude are also required. Postgraduate studies or an MBA, intermediate English proficiency with a high understanding of scientific literature in English, and commercial or pharmaceutical industry experience are desirable.

Responsibilities

The role involves improving the lives of cancer patients by facilitating access to innovative therapies through efficient communication of scientific information and therapeutic value to healthcare stakeholders. Key responsibilities include in-depth knowledge and dissemination of innovative drug science to oncologists, implementing marketing strategies, identifying and addressing barriers to patient access, understanding the healthcare market and its actors, building relationships with stakeholders, prioritizing opportunities, developing action plans, and ensuring compliance with Lilly's processes, policies, and ethical standards.

Skills

Oncology

Sales

Scientific Communication

Marketing Strategy

Stakeholder Relationship Management

Market Analysis

Colombian Healthcare System

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free